[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2560522B1 - Forme d'administration pour absorption percutanee de medicaments, et procede pour sa preparation - Google Patents

Forme d'administration pour absorption percutanee de medicaments, et procede pour sa preparation

Info

Publication number
FR2560522B1
FR2560522B1 FR8500311A FR8500311A FR2560522B1 FR 2560522 B1 FR2560522 B1 FR 2560522B1 FR 8500311 A FR8500311 A FR 8500311A FR 8500311 A FR8500311 A FR 8500311A FR 2560522 B1 FR2560522 B1 FR 2560522B1
Authority
FR
France
Prior art keywords
polymer
drug
mucosa
skin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8500311A
Other languages
English (en)
Other versions
FR2560522A1 (fr
Inventor
Saburo Otsuka
Yuusuke Ito
Shoichi Tokuda
Takashi Kinoshita
Keisuke Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12641636&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2560522(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP59042641A external-priority patent/JPS60185713A/ja
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Publication of FR2560522A1 publication Critical patent/FR2560522A1/fr
Application granted granted Critical
Publication of FR2560522B1 publication Critical patent/FR2560522B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8500311A 1984-03-05 1985-01-10 Forme d'administration pour absorption percutanee de medicaments, et procede pour sa preparation Expired FR2560522B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59042641A JPS60185713A (ja) 1984-03-05 1984-03-05 経皮吸収性製剤及びその製法

Publications (2)

Publication Number Publication Date
FR2560522A1 FR2560522A1 (fr) 1985-09-06
FR2560522B1 true FR2560522B1 (fr) 1988-09-23

Family

ID=12641636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8500311A Expired FR2560522B1 (fr) 1984-03-05 1985-01-10 Forme d'administration pour absorption percutanee de medicaments, et procede pour sa preparation

Country Status (7)

Country Link
US (1) US4719226A (fr)
EP (1) EP0156080B2 (fr)
AT (1) ATE42901T1 (fr)
DE (1) DE3500508A1 (fr)
ES (1) ES8605160A1 (fr)
FR (1) FR2560522B1 (fr)
GB (1) GB2156215B (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
DE3438005A1 (de) * 1984-10-17 1986-04-17 Röhm GmbH, 6100 Darmstadt Pharmazeutisches mittel zur lokalen therapie der psoriasis
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
ATE66157T1 (de) * 1986-04-29 1991-08-15 Hoechst Roussel Pharma Schichtenstruktur fuer die verabreichung von chemikalien mit kontrollierter abgaberate.
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
GR871267B (en) * 1986-08-18 1987-12-24 Chugai Pharmaceutical Co Ltd Method for the manufacture of a pharmaceutical preparation for administration by percutaneous absortion
USRE37934E1 (en) 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US6117448A (en) * 1986-08-28 2000-09-12 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6126963A (en) 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US5820876A (en) * 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
KR970008118B1 (ko) * 1987-07-09 1997-05-21 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 피부 침투성 치료 시스템
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4891227A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891228A (en) * 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
WO1989007951A1 (fr) * 1988-02-26 1989-09-08 Riker Laboratories, Incorporated Systeme d'administration transcutanee d'estradiol
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
JP2681365B2 (ja) * 1988-04-11 1997-11-26 日東電工株式会社 経皮吸収性製剤及びその製法
US5200190A (en) * 1988-10-11 1993-04-06 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous pharmaceutical preparation
DE3843237A1 (de) * 1988-12-22 1990-07-05 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil
DE3843238C1 (fr) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (fr) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
EP0387751B1 (fr) * 1989-03-15 1994-06-08 Nitto Denko Corporation Pansement contenant un médicament
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
JP2849950B2 (ja) * 1990-11-30 1999-01-27 日東電工株式会社 経皮吸収製剤
WO1992014442A1 (fr) * 1991-02-18 1992-09-03 Commonwealth Scientific And Industrial Research Organisation Composition d'administration transdermique
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
ZA932268B (en) * 1992-03-30 1993-11-11 Alza Corp Polymer system containing a partially soluble compound
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
CA2117546A1 (fr) * 1993-08-27 1995-02-28 Takateru Muraoka Feuille adhesive a usage medical
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
HUP0000403A3 (en) * 1995-10-17 2000-10-30 Nitto Denko Corp Percutaneous tulobuterol preparation and process for producing the same
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
TWI248820B (en) * 1999-03-03 2006-02-11 Nitto Denko Corp Oral adhesive sheet and oral adhesive preparation
DE19918105C1 (de) 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
AU5325000A (en) 1999-06-05 2000-12-28 David Houze Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
JP4459414B2 (ja) * 2000-08-24 2010-04-28 日東電工株式会社 口腔内貼付製剤
JP2002080348A (ja) * 2000-08-31 2002-03-19 Nitto Denko Corp 口腔内貼付製剤
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
DE10223835A1 (de) * 2002-05-28 2003-12-11 Labtec Gmbh Pflaster, enthaltend Fentanylum
WO2005011683A1 (fr) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. Preparation pour absorption transdermique
CA2564822A1 (fr) 2004-04-30 2005-11-17 Burrell E. Clawson Appareil et methodes pour isoler des zones du corps humain en vue d'effectuer un refroidissement localise
EP1690528A1 (fr) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Procedé pour la préparation des formes de dosage comprenant une dispersion solide d'un agent active microcristalline
US20090043236A1 (en) * 2005-06-01 2009-02-12 Naohisa Kawamura Skin patch
US20070116664A1 (en) * 2005-11-21 2007-05-24 Shmuel Gonen Methods and compositions for treating hair and skin afflictions
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
US9326979B2 (en) * 2007-03-02 2016-05-03 Teika Pharmaceutical Co., Ltd. Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
JP5371601B2 (ja) * 2008-07-25 2013-12-18 富士フイルム株式会社 プリズムシート用積層フィルム、プリズムシート用積層フィルムの製造方法、プリズムシート、及び表示装置
DE102010053792A1 (de) 2010-12-08 2012-06-14 Frank Becher Flächiges wirkstoffhaltiges System zur Entkeimung von Kontaktflächen
JP7219623B2 (ja) 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632740A (en) * 1968-06-13 1972-01-04 Johnson & Johnson Topical device for the therapeutic management of dermatological lesions with steroids
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
ATE42901T1 (de) 1989-05-15
EP0156080B1 (fr) 1989-05-10
US4719226A (en) 1988-01-12
EP0156080A1 (fr) 1985-10-02
GB2156215A (en) 1985-10-09
DE3500508C2 (fr) 1987-08-06
GB8432737D0 (en) 1985-02-06
DE3500508A1 (de) 1985-09-12
GB2156215B (en) 1988-03-02
ES8605160A1 (es) 1986-04-01
FR2560522A1 (fr) 1985-09-06
EP0156080B2 (fr) 1993-10-20
ES539414A0 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
FR2560522B1 (fr) Forme d'administration pour absorption percutanee de medicaments, et procede pour sa preparation
SE8600947D0 (sv) Farmaceutiska beredningar och forfarande for behandling av minnesrubbningar
US5817331A (en) Transdermal administration of azapirones
DK581685D0 (da) Transderimalt system for timolol-indgift
HUT55643A (en) Process for producing transdermal therapy system containing buprenorfin as agent
PL288852A1 (en) Method of producing a percutaneous therapeutic system with toluberol as an active substance
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
PT88962A (pt) Aparelho aperfeicoado de libertacao transdermica de medicamentos
GB8512358D0 (en) Transdermal delivery system
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
EP0337358A3 (en) Percutaneous absorption type preparation and process for preparing the same
EP0267293A4 (fr) Agent de pretraitement pour administration percutanee.
JPS57209217A (en) Medicament preparation
HUT43959A (en) Medical plasters containing non-continous adhesive layer suitable for getting in therapeutic active agents into skin or through the skin into organism
JPS57183714A (en) Medicinal pharmaceutical
ATE62409T1 (de) Neue arzneimittelzubereitung mit geregelter verabreichung des aktiven mittels, und deren herstellungsverfahren.